Healthy pregnancy hub

Venlafaxine (Effexor®)

Last Update: 09 Apr 2025

Welcome to our fact sheet on venlafaxine (Effexor®) during pregnancy and breastfeeding/ chestfeeding. This information is based on available published literature. It should not take the place of medical care and advice from your healthcare provider.

The HEALTHY PREGNANCY HUB team is collaborating with MotherToBaby to share information on this topic. The original version is available here (updated on November 2023). 

Serene, our chatbot, can also answer your questions about medications during pregnancy. 

Please note that this fact sheet is based on United States information and has been adapted for Canada, with a review by our Canadian experts. Minor differences may exist between the two countries. Always consult your healthcare professional for information tailored to your situation. 

1. What is venlafaxine?

Venlafaxine is a medication that has been used to treat depression, panic disorder, social phobia, and anxiety. It has also been used to treat attention deficit hyperactivity disorder (ADHD), binge eating disorder, bipolar disorder, diabetic neuropathy, obsessive-compulsive disorder (OCD), posttraumatic stress disorder (PTSD), premenstrual dysphoric disorder, and tension-type headaches. Venlafaxine is sold under the brand name Effexor®. 

Sometimes when people find out they are pregnant, they think about changing how they take their medication, or stopping their medication altogether. However, it is important to talk with your healthcare providers before making any changes to how you take your medication. Your healthcare providers can talk with you about the benefits of treating your condition and the risks of untreated illness during pregnancy. 

Some people might have a return of their symptoms (relapse) if they stop this medication. If you plan to stop this medication, your healthcare provider might suggest that you slowly lower the dose instead of stopping all at once. Stopping this medication suddenly can cause some people to have withdrawal symptoms. It is not known what effect, if any, withdrawal could have on a pregnancy. 

2. What are the risks according to research?

I take venlafaxine. Can it make it harder for me to get pregnant?

It is not known if venlafaxine can make it harder to get pregnant. There are a few reports of people having higher levels of a hormone called prolactin. High levels of prolactin can stop ovulation (part of the menstrual cycle when an ovary releases an egg). This might make it harder to get pregnant. 

Does taking venlafaxine increase the chance of miscarriage?

Miscarriage is common and can occur in any pregnancy for many different reasons. One study suggested that people taking venlafaxine might have an increased chance of miscarriage, while other studies have not. Depression itself might increase the chance of miscarriage, which makes it hard to know if the medication, the condition it treats, or other factors are the cause of a miscarriage. 

Does taking venlafaxine increase the chance of birth defects?

Every pregnancy starts out with a 3-5% chance of having a birth defect. This is called the background risk. While some studies suggest a possible increased chance of birth defects when taking venlafaxine during pregnancy, several large studies have not. If there is an increased chance of birth defects above the background risk with use of venlafaxine in pregnancy, it is likely to be small. 

Does taking venlafaxine in pregnancy increase the chance of other pregnancy-related problems?

Some studies have suggested a higher chance for preterm delivery (birth before week 37) when venlafaxine is used in pregnancy, while other studies have not. When depression is untreated or not well-treated during pregnancy, there could be an increased chance of pregnancy complications. For more information, please see MotherToBaby fact sheet on depression here

One study found an increased chance of developing gestational diabetes in individuals taking venlafaxine during pregnancy while a second study did not. For more information on gestational diabetes, see our fact sheet here

I need to take venlafaxine throughout my entire pregnancy. Will it cause withdrawal symptoms in my baby after birth?

The use of venlafaxine during pregnancy can cause temporary symptoms in newborns soon after birth. These symptoms are sometimes referred to as withdrawal and can include jitteriness, increased muscle tone, irritability, changes in sleep patterns, tremors, seizures, trouble eating, and problems with breathing. Some babies might need to stay in the hospital for several days. Most of the time these effects are mild and go away on their own. Not all babies exposed to venlafaxine will have these symptoms. It is important that your healthcare providers know you are taking venlafaxine so that if symptoms occur your baby can get the care that is best for them. 

Does taking venlafaxine in pregnancy affect future behavior or learning for the child?

It is not known if venlafaxine increases the chance for behavior or learning issues for the child. One study found no difference in IQ or behavioral problems in 4 year olds who had been exposed to venlafaxine in pregnancy when compared to children whose mothers had depression but were not treated during pregnancy. A second study found a small increase in the chances of autism spectrum disorder in children exposed to venlafaxine during pregnancy. However, it is not clear whether this was related to the medication, the condition being treated, or other factors. 

3. Breastfeeding/ chestfeeding while taking venlafaxine

Venlafaxine passes into breastmilk/ human milk. Side effects in children who are nursing have sometimes been reported. If you suspect the baby has any symptoms (being more sleepy or irritable than usual, poor feeding, trouble with gaining weight) contact the child’s healthcare provider. If there is a concern, infant blood levels can be taken. 

The product label for venlafaxine recommends people who are breastfeeding/ chestfeeding not use this medication. But the benefits of taking venlafaxine and the benefits of breastfeeding/ chestfeeding your child might outweigh the risks of an untreated mental health condition. Your healthcare provider can talk with you about venlafaxine and what treatment is best for you. Be sure to talk to your healthcare provider about all your breastfeeding/ chestfeeding questions. 

4. Fathers and sperm donors

If a male takes venlafaxine, could it affect fertility or increase the chance of birth defects?

Studies have not been done in humans to see if venlafaxine could affect a male’s fertility (ability to get a partner pregnant) or increase the chance of birth defects above the background risk. There are a few reports of males having higher prolactin levels when taking venlafaxine, which might affect fertility. In general, exposures that fathers or sperm donors have are unlikely to increase risks to a pregnancy. For more information, please see the MotherToBaby fact sheet Paternal Exposures here. 

Key points

  • Venlafaxine (Effexor®) is an antidepressant in the serotonin-norepinephrine reuptake inhibitor (SNRI) class. It is used to treat depression, anxiety, and other disorders.
  • Studies on venlafaxine use during pregnancy have shown mixed results. Some studies suggest a slightly higher risk of birth defects, preterm birth, or gestational diabetes, while others do not show an increased risk.
  • Babies exposed to venlafaxine in late pregnancy may experience temporary symptoms after birth.
  • Venlafaxine passes into breast milk/ human milk, and some nursing babies may experience side effects.
  • It is important to talk with your healthcare provider before stopping or changing your treatment.

References

Please click here to view references. 

URL copied!

Disclaimer

HEALTHY PREGNANCY HUB provides a source of information validated by health professionals; however, this information is provided for informational purposes only and should not replace professional advice. Medical standards and practices evolve as new data becomes available, so it is imperative to consult your doctor or a qualified health professional for any questions or concerns regarding your health without delay or omission. It is the responsibility of your treating physician or any other health professional, based on their independent experience and knowledge of the patient, to determine the best way to evaluate and treat you.

HEALTHY PREGNANCY HUB does not specifically recommend or endorse any test, practitioner, treatment, product, or opinion mentioned on our platform. HEALTHY PREGNANCY HUB also does not replace the individual patient assessment based on the examination by the healthcare provider of each patient and the consideration of laboratory data and other patient-specific factors.

The use of the information available on our site is at your own risk. No person involved in the creation, production, promotion, or marketing of HEALTHY PREGNANCY HUB guarantees or represents, expressly or implicitly, anything regarding the information available on the platform, which is provided “as it is”. All warranties are expressly excluded and disclaimed, including but not limited to implied warranties of merchantability or fitness for a particular purpose, as well as any warranties arising by law or otherwise in law or from trade or usage. Any statements or representations made by any other person or entity are void.

While consulting symptoms or other medical information on our platform may guide your discussions with your healthcare professional, this information should not be used to make a medical diagnosis or determine treatment. Before making changes to your supplement or medication regimen, please discuss with your medical team or contact 811 (Canada) to ensure the relevance of these changes to your individual situation.

Credits
MotherToBaby
Organization of Teratology Information Specialists (OTIS)
View source
Émy Roberge
Centre hospitalier universitaire Sainte-Justine
Brigitte Martin
Centre Hospitalier Universitaire Sainte-Justine

Associated Fact Sheets

Would you like to know more? Explore our Fact Sheets associated to venlafaxine.

Associated Resources

Would you like to know more about mental health? Explore our other resources, including videos and pamphlet, on the topic.

Partners

Your pregnancy during COVID-19
uOttawa
University of Calgary
University of British Columbia
University of Saskatchewan
University of Manitoba
University of Alberta
Unité de soutien SSA
UDEM
Stratos
SOGC
RQRM
QTNPR
QPC
PWHR
Public Health Agency of Canada
PregMed France
SPOR
MPrint
Mitacs
Médicaments Grossesse
McGill
Médicament Québec
FRQ
Perinatal Network
CIHR
IQVIA
iPOP
Institut national de santé publique du Québec
INRS
Innovative Medicines Canada
IN-uTERO
Immerscience
Groww
Enrich
Design Develop Discover
CUSM
CIHR
CHU Sainte-Justine
Centre of Excellence on Partnership with Patients and the Public
CAN-AIM
Canadian Pharmacogenomics Network for Drug Safetry
CAMCCO
CAMCCO-L
C4T
BORN Ontario
Black Physicians of Canada
BC Children's Hospital
Alberta Health Services
MICYRN
UQAT
Dalhousie University